Intravenous immunoglobulin treatment of neurological autoimmune diseases

This publication has 98 references indexed in Scilit:

• Campylobacter jejuniInfection and Treatment for Guillain–Barré Syndrome
  New England Journal of Medicine, 1996
• Recommendations for off-label use of intravenously administered immunoglobulin preparations. University Hospital Consortium Expert Panel for Off-Label Use of Polyvalent Intravenously Administered Immunoglobulin Preparations
  Published by American Medical Association (AMA) ,1995
• Myasthenia Gravis
  New England Journal of Medicine, 1994
• Spontaneous Recovery from the Guillain-Barré Syndrome Is Associated with Anti-idiotypic Antibodies Recognizing a Cross-Reactive Idiotype on Anti-neuroblastoma Cell Line Antibodies
  Clinical Immunology and Immunopathology, 1993
• The effects of intravenous immune globulin on complement-dependent immune damage of cells and tissues
  Clinical Immunology and Immunopathology, 1992
• Transient Neutropenia Induced by Intravenous Immune Globulin
  New England Journal of Medicine, 1992
• The immune complex: possible ways of regulating the antibody response
  Immunology Today, 1990
• Immunoglobulin G Subclass Distribution in Three Human Intravenous Immunoglobulin Preparations
  Vox Sanguinis, 1989
• Anaphylactic Reactions after Gamma Globulin Administration in Patients with Hypogammaglobulinemia
  New England Journal of Medicine, 1986
• Fc-depleted vs intact intravenous immunoglobulin in chronic ITP
  The Journal of Pediatrics, 1984